Skip to main content

Table 2 Bone mineral density assessments performed and results for entire cohort by gender

From: The association of time and medications with changes in bone mineral density in the 2 years after critical illness

  All (n = 92a) Women (n = 44a) Men (n = 48a)
Variable Baseline 1 year 2 years Baseline 1 year 2 years Baseline 1 year 2 years
BMD studies performed 92 66 48 44 31 22 48 35 26
 Anti-fracture therapy in prior year - 4 (6.1) 10 (20.8) - 3 (9.7) 6 (27.3) - 1 (2.9) 4 (15.4)
 Glucocorticoid in prior year - 3 (4.5) 5 (10.4) - 2 (6.5) 5 (22.7) - 1 (2.9) 0 (0)
BMD measurement
 Femur T-score - 0.8 (±1.5) -1.0 (±1.4) - 1.1 (±1.3) - 1.2 (±1.4) - 1.3 (±1.2) - 1.4 (±0.9) - 0.5 (±1.4) - 0.7 (±1.5) - 1.0 (±1.6)
 Femur absolute (g/cm3) 0.956 (±0.197) 0.940 (±0.193) 0.923 (±0.178) 0.876 (±0.176) 0.872 (±0.161) 0.871 (±0.126) 1.028 (±0.187) 0.999 (±0.202) 0.964 (±0.203)
 AP spine T-score - 0.2 (±1.9) - 0.2 (±1.9) - 0.1 (±1.9) - 0.7 (±1.8) - 0.6 (±1.6) - 0.5 (±1.2) 0.3 (±1.8) 0.2 (±2.0) 0.3 (±2.2)
 AP spine absolute (g/cm3) 1.207 (±0.242) 1.205 (±0.241) 1.211 (±0.231) 1.135 (±0.250) 1.142 (±0.223) 1.151 (±0.173) 1.273 (±0.217) 1.260 (±0.246) 1.262 (±0.264)
  1. Data are shown as mean (±standard deviation) or number (%)
  2. Abbreviations: BMD bone mineral density, AP anterioposterior
  3. aAt baseline femur BMD not measured in three participants (one woman, two men). At 1 year femur BMD not measured in two participants (one woman, one man), at 2 years femur BMD not measured in one participant (one woman)